Designing Health Benefits for Different Clinical Journeys

Women and men experience very different clinical journeys across the lifespan, and a one-size-fits-all approach to medical and pharmacy benefits carries real risk to both outcomes and total cost of care. Treating women’s health as a series of disconnected services rather than a unified strategy overlooks important clinical nuance and creates avoidable inefficiencies. Emerging evidence reinforces the need for this distinction. Recent research shows that early menopause, while associated with conditions such as cardiovascular disease and bone loss, is not linked to a higher risk of type 2 diabetes, with women entering menopause before age 45 showing similar diabetes risk to those who transition later in life (Quesada et al., 2026). Designing benefits around sex-specific clinical realities allows care to be more precise, reduces unnecessary utilization, and supports better outcomes for all members. Creating a holistic women’s health strategy is therefore a critical next step in optimizing benefit design and managing total cost of care.

Quesada, J. A., Bertomeu-Gonzalez, V., Cordero, A., Ruiz-Nodar, J. M., Sanchez-Ferrer, F. P., Lopez-Ayala, J. M., Cazorla, D., Soriano-Maldonado, C., & Arrarte, V. (2026). Timing and type of menopause are not risk factors for the onset of diabetes: A UK Biobank cohort study. The Journal of The Menopause Society. https://doi.org/10.1097/GME.0000000000002720